{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:37Z","timestamp":1792788277037,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Helmholtz Zentrum M\u00fcnchen - Deutsches Forschungszentrum f\u00fcr Gesundheit und Umwelt (GmbH)","id":[{"id":"https:\/\/ror.org\/00cfam450","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurotropic viruses infect the central nervous system (CNS) resulting in severe neurological and long-term complications, including permanent cognitive impairments. However, for many of these neurotropic viruses, like tick-borne encephalitis virus (TBEV), there are no clinically approved antiviral drugs. The blood-brain barrier (BBB) is a key entry point for neurotropic viruses, as well as a barrier for drug delivery to the brain. To aid in the identification of BBB-penetrating antivirals we established a BBB-permeable antiviral screening assay (BASA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BASA combines antiviral assays with an in vitro BBB transwell model consisting of primary human brain microvascular endothelial cells (HMBEC) and pericytes (HBMVP). The combination of our in vitro BBB transwell model with astrocyte-enriched cell cultures provided a tri-culture model to investigate TBEV infection at the BBB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The suitability of BASA for identifying BBB-permeable antivirals was validated by testing clinically approved anti-human immunodeficiency virus (HIV) drugs with known CNS-penetrating properties. Infection experiments reveal that TBEV crosses the intact BBB to infect astrocytic target cells. Through the application of BASA, we identify a novel BBB-permeable antiviral against TBEV (compound 3d).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We establish a modular assay system for the early evaluation of CNS penetration potential of novel antiviral compounds. The development of tools like ours can help promote early-stage preclinical optimization of dedicated therapeutics against neurotropic viruses, while reducing the need for animal experiments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-026-00860-z","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:20:23Z","timestamp":1790230823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment of an in vitro human blood-brain barrier model for antiviral screening against neurotropic viruses"],"prefix":"10.1186","volume":"23","author":[{"given":"Marisol","family":"Zuniga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Rizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Himl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Zischka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romano","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brancale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim J.","family":"Bugert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Brack-Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"860_CR1","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ymthe.2022","volume":"30","author":"GT Szab\u00f3","year":"2022","unstructured":"Szab\u00f3 GT, Mahiny AJ, Vlatkovic I. COVID-19 mRNA vaccines: Platforms and current developments. Mol Ther. 2022;30:1850\u201368. https:\/\/doi.org\/10.1016\/j.ymthe.2022. 02.016 PubMed PMID: 35189345.","journal-title":"Mol Ther"},{"key":"860_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1057\/s41599-025-05267-z","volume":"12","author":"J Zilinsky","year":"2025","unstructured":"Zilinsky J, Theocharis Y. Conspiracism and government distrust predict COVID-19 vaccine refusal. Humanit Soc Sci Commun. 2025;12:1002. https:\/\/doi.org\/10.1057\/s41599-025-05267-z.","journal-title":"Humanit Soc Sci Commun"},{"key":"860_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-023-00692-8","volume":"22","author":"A von Delft","year":"2023","unstructured":"von Delft A, Hall MD, Kwong AD, Purcell LA, Saikatendu KS, Schmitz U, et al. Accelerating antiviral drug discovery: lessons from COVID-19. Nat Rev Drug Discov. 2023;22:585\u2013603. https:\/\/doi.org\/10.1038\/s41573-023-00692-8. PubMed PMID: 37173515.","journal-title":"Nat Rev Drug Discov"},{"key":"860_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.53854\/liim-3204-5","volume":"32","author":"BM Ukoaka","year":"2024","unstructured":"Ukoaka BM, Okesanya OJ, Daniel FM, Ahmed MM, Udam NG, Wagwula PM, et al. Updated WHO list of emerging pathogens for a potential future pandemic: Implications for public health and global preparedness. Infez Med. 2024;32:463\u201377. https:\/\/doi.org\/10.53854\/liim-3204-5. PubMed PMID: 39660154.","journal-title":"Infez Med"},{"key":"860_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-015-1511-3","volume":"131","author":"M Ludlow","year":"2016","unstructured":"Ludlow M, Kortekaas J, Herden C, Hoffmann B, Tappe D, Trebst C, et al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol. 2016;131:159\u201384. https:\/\/doi.org\/10.1007\/s00401-015-1511-3. PubMed PMID: 26659576.","journal-title":"Acta Neuropathol"},{"key":"860_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2014","volume":"11","author":"PA Swanson","year":"2015","unstructured":"Swanson PA, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44\u201354. https:\/\/doi.org\/10.1016\/j.coviro.2014. 12.009 PubMed PMID: 25681709.","journal-title":"Curr Opin Virol"},{"key":"860_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/newbio244121a","volume":"244","author":"PP Giorgi","year":"1973","unstructured":"Giorgi PP, Karlsson JC, Sj\u00f6strand J, Field EJ. Axonal flow and myelin protein in the optic pathway. Nat New Biol. 1973;244:121\u20134. https:\/\/doi.org\/10.1038\/newbio244121a. 0 PubMed PMID: 4124302.","journal-title":"Nat New Biol"},{"key":"860_CR8","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s12035-023-03761-6","volume":"61","author":"P Wongchitrat","year":"2024","unstructured":"Wongchitrat P, Chanmee T, Govitrapong P. Molecular mechanisms associated with neurodegeneration of neurotropic viral infection. Mol Neurobiol. 2024;61:2881\u2013903. https:\/\/doi.org\/10.1007\/s12035-023-03761-6. PubMed PMID: 37946006.","journal-title":"Mol Neurobiol"},{"key":"860_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12967-024-06025-6","volume":"23","author":"S Shouman","year":"2025","unstructured":"Shouman S, Hesham N, Salem TZ. Viruses and neurodegeneration: a growing concern. J Transl Med. 2025;23:46. https:\/\/doi.org\/10.1186\/s12967-024-06025-6. PubMed PMID: 39800721.","journal-title":"J Transl Med"},{"key":"860_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10571-025-01622-5","volume":"45","author":"A Mohabbat","year":"2025","unstructured":"Mohabbat A, Bannazadeh Baghi H. Chronic neuroplasticity changes following neurotropic viral infection: Mechanisms and implications. Cell Mol Neurobiol. 2025;45:94. https:\/\/doi.org\/10.1007\/s10571-025-01622-5. PubMed PMID: 41186612.","journal-title":"Cell Mol Neurobiol"},{"key":"860_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40263-024-01082-3","volume":"38","author":"M Sun","year":"2024","unstructured":"Sun M, Manson ML, Guo T, de Lange ECM. CNS viral infections-what to consider for improving drug treatment: A plea for using mathematical modeling approaches. CNS Drugs. 2024;38:349\u201373. https:\/\/doi.org\/10.1007\/s40263-024-01082-3. PubMed PMID: 38580795.","journal-title":"CNS Drugs"},{"key":"860_CR12","doi-asserted-by":"publisher","unstructured":"Pustijanac E, Bur\u0161i\u0107 M, Talapko J, \u0160krlec I, Me\u0161trovi\u0107 T, Li\u0161nji\u0107 D. Tick-borne encephalitis virus: a comprehensive review of transmission, pathogenesis, epidemiology, clinical manifestations, diagnosis, and prevention. Microorganisms. 2023;11. https:\/\/doi.org\/10.3390\/microorganisms11071634. PubMed PMID: 37512806.","DOI":"10.3390\/microorganisms11071634"},{"key":"860_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.12998\/wjcc.v3.i5","volume":"3","author":"P Bogovic","year":"2015","unstructured":"Bogovic P, Strle F. Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. World J Clin Cases. 2015;3:430\u201341. https:\/\/doi.org\/10.12998\/wjcc.v3.i5..430 PubMed PMID: 25984517.","journal-title":"World J Clin Cases"},{"key":"860_CR14","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3389\/fimmu.2018.02174","volume":"9","author":"K Blom","year":"2018","unstructured":"Blom K, Cuapio A, Sandberg JT, Varnaite R, Micha\u00eblsson J, Bj\u00f6rkstr\u00f6m NK, et al. Cell-mediated immune responses and immunopathogenesis of human tick-borne encephalitis virus-infection. Front Immunol. 2018;9:2174. https:\/\/doi.org\/10.3389\/fimmu.2018.02174. PubMed PMID: 30319632.","journal-title":"Front Immunol"},{"key":"860_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fneur.2017.00119","volume":"8","author":"P Sendi","year":"2017","unstructured":"Sendi P, Hirzel C, Pfister S, Ackermann-G\u00e4umann R, Grandgirard D, Hewer E, et al. Fatal outcome of European tick-borne encephalitis after vaccine failure. Front Neurol. 2017;8:119. https:\/\/doi.org\/10.3389\/fneur.2017.00119. PubMed PMID: 28421031.","journal-title":"Front Neurol"},{"key":"860_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/jnen\/64","volume":"64","author":"E Gelpi","year":"2005","unstructured":"Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka H. Visualization of Central European tick-borne encephalitis infection in fatal human cases. J Neuropathol Exp Neurol. 2005;64:506\u201312. https:\/\/doi.org\/10.1093\/jnen\/64..6.506 PubMed PMID: 15977642.","journal-title":"J Neuropathol Exp Neurol"},{"key":"860_CR17","doi-asserted-by":"publisher","unstructured":"Stone ET, Pinto AK. T cells in tick-borne flavivirus encephalitis: a review of current paradigms in protection and disease pathology. Viruses. 2023;15. https:\/\/doi.org\/10.3390\/v15040958. PubMed PMID: 37112938.","DOI":"10.3390\/v15040958"},{"key":"860_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69. https:\/\/doi.org\/10.1186\/s12987-020-00230-3. PubMed PMID: 33208141.","journal-title":"Fluids Barriers CNS"},{"key":"860_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx. 2005;2:86\u201398. https:\/\/doi.org\/10.1602\/neurorx.2..1.86 PubMed PMID: 15717060.","journal-title":"NeuroRx"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41\u201353. https:\/\/doi.org\/10.1038\/nrn1824. PubMed PMID: 16371949.","journal-title":"Nat Rev Neurosci"},{"key":"860_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tcb.2023.06","volume":"34","author":"H van Splunder","year":"2024","unstructured":"van Splunder H, Villacampa P, Mart\u00ednez-Romero A, Graupera M. Pericytes in the disease spotlight. Trends Cell Biol. 2024;34:58\u201371. https:\/\/doi.org\/10.1016\/j.tcb.2023.06..001 PubMed PMID: 37474376.","journal-title":"Trends Cell Biol"},{"key":"860_CR22","doi-asserted-by":"publisher","first-page":"862053","DOI":"10.3389\/fimmu.2022.862053","volume":"13","author":"O Constant","year":"2022","unstructured":"Constant O, Maarifi G, Blanchet FP, Van de Perre P, Simonin Y, Salinas S. Role of dendritic cells in viral brain infections. Front Immunol. 2022;13:862053. https:\/\/doi.org\/10.3389\/fimmu.2022.862053. PubMed PMID: 35529884.","journal-title":"Front Immunol"},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217. https:\/\/doi.org\/10.1038\/s41392-023-. 01481-w PubMed PMID: 37231000.","journal-title":"Signal Transduct Target Ther"},{"key":"860_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","volume":"7","author":"E Nance","year":"2021","unstructured":"Nance E, Pun SH, Saigal R, Sellers DL. Drug delivery to the central nervous system. Nat Rev Mater. 2021;7:314\u201331. https:\/\/doi.org\/10.1038\/s41578-021-00394-w.","journal-title":"Nat Rev Mater"},{"key":"860_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1750-3639.1998.tb","volume":"8","author":"CA Wiley","year":"1998","unstructured":"Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, et al. Distribution of brain HIV load in AIDS. Brain Pathol. 1998;8:277\u201384. https:\/\/doi.org\/10.1111\/j.1750-3639.1998.tb. 00153.x PubMed PMID: 9546286.","journal-title":"Brain Pathol"},{"key":"860_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","volume":"43","author":"O Osborne","year":"2020","unstructured":"Osborne O, Peyravian N, Nair M, Daunert S, Toborek M. The paradox of HIV blood-brain barrier penetrance and antiretroviral drug delivery deficiencies. Trends Neurosci. 2020;43:695\u2013708. https:\/\/doi.org\/10.1016\/j.tins.2020.06.007. PubMed PMID: 32682564.","journal-title":"Trends Neurosci"},{"key":"860_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fncel.2014.00335","volume":"8","author":"JAG Ag\u00fandez","year":"2014","unstructured":"Ag\u00fandez JAG, Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E. Drug and xenobiotic biotransformation in the blood-brain barrier: a neglected issue. Front Cell Neurosci. 2014;8:335. https:\/\/doi.org\/10.3389\/fncel.2014.00335. PubMed PMID: 25368552.","journal-title":"Front Cell Neurosci"},{"key":"860_CR28","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1128\/AAC.00515-10","volume":"54","author":"S Kremb","year":"2010","unstructured":"Kremb S, Helfer M, Heller W, Hoffmann D, Wolff H, Kleinschmidt A, et al. EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors. Antimicrob Agents Chemother. 2010;54:5257\u201368. https:\/\/doi.org\/10.1128\/AAC.00515-10. PubMed PMID: 20876377.","journal-title":"Antimicrob Agents Chemother"},{"key":"860_CR29","doi-asserted-by":"publisher","unstructured":"Bassetto M, Cima CM, Basso M, Salerno M, Schwarze F, Friese D, et al. Novel nucleoside analogues as effective antiviral agents for Zika virus infections. Molecules. 2020;25. https:\/\/doi.org\/10.3390\/molecules25204813. PubMed PMID: 33092055.","DOI":"10.3390\/molecules25204813"},{"key":"860_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0042-6822","volume":"185","author":"K Peden","year":"1991","unstructured":"Peden K, Emerman M, Montagnier L. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology. 1991;185:661\u201372. https:\/\/doi.org\/10.1016\/0042-6822. (91)90537-l PubMed PMID: 1683726.","journal-title":"Virology"},{"key":"860_CR31","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s41598-020-57843-9","volume":"10","author":"A Herrmann","year":"2020","unstructured":"Herrmann A, Roesner M, Werner T, Hauck SM, Koch A, Bauer A, et al. Potent inhibition of HIV replication in primary human cells by novel synthetic polyketides inspired by Aureothin. Sci Rep. 2020;10:1326. https:\/\/doi.org\/10.1038\/s41598-020-57843-9. PubMed PMID: 31992748.","journal-title":"Sci Rep"},{"key":"860_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","volume":"36","author":"C Lei","year":"2021","unstructured":"Lei C, Yang J, Hu J, Sun X. On the calculation of TCID50 for quantitation of virus infectivity. Virol Sin. 2021;36:141\u20134. https:\/\/doi.org\/10.1007\/s12250-020-00230-5. PubMed PMID: 32458296.","journal-title":"Virol Sin"},{"key":"860_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/s1386-6532","volume":"27","author":"M Schwaiger","year":"2003","unstructured":"Schwaiger M, Cassinotti P. Development of a quantitative real-time RT-PCR assay with internal control for the laboratory detection of tick borne encephalitis virus (TBEV) RNA. J Clin Virol. 2003;27:136\u201345. https:\/\/doi.org\/10.1016\/s1386-6532. (02)00168-3 PubMed PMID: 12829035.","journal-title":"J Clin Virol"},{"key":"860_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/10611860290031903","volume":"10","author":"C Lohmann","year":"2002","unstructured":"Lohmann C, H\u00fcwel S, Galla HJ. Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. J Drug Target. 2002;10:263\u201376. https:\/\/doi.org\/10.1080\/10611860290031903.\u00a0PubMed PMID: 12164375.","journal-title":"J Drug Target"},{"key":"860_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/biores.2019.0026","volume":"8","author":"M Ohshima","year":"2019","unstructured":"Ohshima M, Kamei S, Fushimi H, Mima S, Yamada T, Yamamoto T. Prediction of drug permeability using in vitro blood-brain barrier models with human induced pluripotent stem cell-derived brain microvascular endothelial cells. Biores Open Access. 2019;8:200\u20139. https:\/\/doi.org\/10.1089\/biores.2019.0026. PubMed PMID: 31737437.","journal-title":"Biores Open Access"},{"key":"860_CR36","doi-asserted-by":"publisher","unstructured":"Yang JY, Shin DS, Jeong M, Kim SS, Jeong HN, Lee BH, et al. Evaluation of drug blood-brain-barrier permeability using a microfluidic chip. Pharmaceutics. 2024;16. https:\/\/doi.org\/10.3390\/pharmaceutics16050574. PubMed PMID: 38794236.","DOI":"10.3390\/pharmaceutics16050574"},{"key":"860_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617","volume":"35","author":"UH Langen","year":"2019","unstructured":"Langen UH, Ayloo S, Gu C. Development and cell biology of the blood-brain barrier. Annu Rev Cell Dev Biol. 2019;35:591\u2013613. https:\/\/doi.org\/10.1146\/annurev-cellbio-100617. -062608 PubMed PMID: 31299172.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"860_CR38","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1177\/0271678X17708690","volume":"38","author":"AM Andrews","year":"2018","unstructured":"Andrews AM, Lutton EM, Cannella LA, Reichenbach N, Razmpour R, Seasock MJ, et al. Characterization of human fetal brain endothelial cells reveals barrier properties suitable for in vitro modeling of the BBB with syngenic co-cultures. J Cereb Blood Flow Metab. 2018;38:888\u2013903. https:\/\/doi.org\/10.1177\/0271678X17708690.\u00a0PubMed PMID: 28534661.","journal-title":"J Cereb Blood Flow Metab"},{"key":"860_CR39","doi-asserted-by":"publisher","first-page":"26587","DOI":"10.1038\/srep26587","volume":"6","author":"TIH Park","year":"2016","unstructured":"Park TIH, Feisst V, Brooks AES, Rustenhoven J, Monzo HJ, Feng SX, et al. Cultured pericytes from human brain show phenotypic and functional differences associated with differential CD90 expression. Sci Rep. 2016;6:26587. https:\/\/doi.org\/10.1038\/srep26587. PubMed PMID: 27215737.","journal-title":"Sci Rep"},{"key":"860_CR40","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","volume":"13","author":"S Bergmann","year":"2018","unstructured":"Bergmann S, Lawler SE, Qu Y, Fadzen CM, Wolfe JM, Regan MS, et al. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat Protoc. 2018;13:2827\u201343. https:\/\/doi.org\/10.1038\/s41596-018-0066-x. PubMed PMID: 30382243.","journal-title":"Nat Protoc"},{"key":"860_CR41","doi-asserted-by":"publisher","first-page":"15623","DOI":"10.1038\/ncomms15623","volume":"8","author":"CF Cho","year":"2017","unstructured":"Cho CF, Wolfe JM, Fadzen CM, Calligaris D, Hornburg K, Chiocca EA, et al. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun. 2017;8:15623. https:\/\/doi.org\/10.1038\/ncomms15623. PubMed PMID: 28585535.","journal-title":"Nat Commun"},{"key":"860_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12987-025-00727-9","volume":"22","author":"F Guo","year":"2025","unstructured":"Guo F, Chen J, Wang L, Li M, Lv Q, Wang J, et al. Hydrogel-based microfluidic model of the blood-brain barrier: progress and future perspectives. Fluids Barriers CNS. 2025;22:119. https:\/\/doi.org\/10.1186\/s12987-025-00727-9. PubMed PMID: 41291814.","journal-title":"Fluids Barriers CNS"},{"key":"860_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12987-020-00183-7","volume":"17","author":"A Bhalerao","year":"2020","unstructured":"Bhalerao A, Sivandzade F, Archie SR, Chowdhury EA, Noorani B, Cucullo L. In vitro modeling of the neurovascular unit: advances in the field. Fluids Barriers CNS. 2020;17:22. https:\/\/doi.org\/10.1186\/s12987-020-00183-7. PubMed PMID: 32178700.","journal-title":"Fluids Barriers CNS"},{"key":"860_CR44","doi-asserted-by":"publisher","first-page":"204173142412355","DOI":"10.1177\/20417314241235527","volume":"15","author":"AB Salmina","year":"2024","unstructured":"Salmina AB, Alexandrova OP, Averchuk AS, Korsakova SA, Saridis MR, Illarioshkin SN, et al. Current progress and challenges in the development of brain tissue models: How to grow up the changeable brain in vitro? J Tissue Eng. 2024;15:20417314241235530. https:\/\/doi.org\/10.1177\/20417314241235527.\u00a0PubMed PMID: 38516227.","journal-title":"J Tissue Eng"},{"key":"860_CR45","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/brain\/awaa268","volume":"143","author":"P Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou P, Rauti R, Voulgaris D, Shlomy I, Maoz BM, Herland A. Recent progress in translational engineered in vitro models of the central nervous system. Brain. 2020;143:3181\u2013213. https:\/\/doi.org\/10.1093\/brain\/awaa268. PubMed PMID: 33020798.","journal-title":"Brain"},{"key":"860_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/bcp.12403","volume":"79","author":"A Tseng","year":"2015","unstructured":"Tseng A, Seet J, Phillips EJ. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Br J Clin Pharmacol. 2015;79:182\u201394. https:\/\/doi.org\/10.1111\/bcp.12403. PubMed PMID: 24730660.","journal-title":"Br J Clin Pharmacol"},{"key":"860_CR47","doi-asserted-by":"publisher","unstructured":"Arentoft A, Troxell K, Alvarez K, Aghvinian M, Rivera Mindt M, Cherner M, et al. HIV antiretroviral medication neuropenetrance and neurocognitive outcomes in HIV+ adults: a review of the literature examining the central nervous system penetration effectiveness score. Viruses. 2022;14. https:\/\/doi.org\/10.3390\/v14061151. PubMed PMID: 35746623.","DOI":"10.3390\/v14061151"},{"key":"860_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/aid","volume":"8","author":"PM Grob","year":"1992","unstructured":"Grob PM, Wu JC, Cohen KA, Ingraham RH, Shih CK, Hargrave KD, et al. Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug. AIDS Res Hum Retroviruses. 1992;8:145\u201352. https:\/\/doi.org\/10.1089\/aid..1992.8.145 PubMed PMID: 1371691.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"860_CR49","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1128\/AAC.41.5.1082","volume":"41","author":"SM Daluge","year":"1997","unstructured":"Daluge SM, Good SS, Faletto MB, Miller WH, St Clair MH, Boone LR, et al. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob Agents Chemother. 1997;41:1082\u201393. https:\/\/doi.org\/10.1128\/AAC.41.5.1082. PubMed PMID: 9145874.","journal-title":"Antimicrob Agents Chemother"},{"key":"860_CR50","doi-asserted-by":"publisher","first-page":"205031212412298","DOI":"10.1177\/20503121241229847","volume":"12","author":"BS Srichawla","year":"2024","unstructured":"Srichawla BS, Manan MR, Kipkorir V, Dhali A, Diebel S, Sawant T, et al. Neuroinvasion of emerging and re-emerging arboviruses: A scoping review. SAGE Open Med. 2024;12:20503121241229850. https:\/\/doi.org\/10.1177\/20503121241229847.\u00a0PubMed PMID: 38711470.","journal-title":"SAGE Open Med"},{"issue":"Pt 5","key":"860_CR51","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1099\/0022-1317-77-5-1035","volume":"77","author":"G Wallner","year":"1996","unstructured":"Wallner G, Mandl CW, Ecker M, Holzmann H, Stiasny K, Kunz C, et al. Characterization and complete genome sequences of high- and low- virulence variants of tick-borne encephalitis virus. J Gen Virol. 1996;77(Pt 5):1035\u201342. https:\/\/doi.org\/10.1099\/0022-1317-77-5-1035. PubMed PMID: 8609469.","journal-title":"J Gen Virol"},{"key":"860_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2017.04.012","volume":"507","author":"M Palus","year":"2017","unstructured":"Palus M, Vancova M, Sirmarova J, Elsterova J, Perner J, Ruzek D. Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity. Virology. 2017;507:110\u201322. https:\/\/doi.org\/10.1016\/j.virol.2017.04.012. PubMed PMID: 28432926.","journal-title":"Virology"},{"key":"860_CR53","doi-asserted-by":"publisher","unstructured":"van den Elsen K, Quek JP, Luo D. Molecular insights into the flavivirus replication complex. Viruses. 2021;13. https:\/\/doi.org\/10.3390\/v13060956. PubMed PMID: 34064113.","DOI":"10.3390\/v13060956"},{"key":"860_CR54","doi-asserted-by":"publisher","unstructured":"Butsabong T, Felippe M, Campagnolo P, Maringer K. The emerging role of perivascular cells (pericytes) in viral pathogenesis. J Gen Virol. 2021;102. https:\/\/doi.org\/10.1099\/jgv.0.001634. PubMed PMID: 34424156.","DOI":"10.1099\/jgv.0.001634"},{"key":"860_CR55","doi-asserted-by":"publisher","unstructured":"Jorga\u010devski J, Potokar M. Immune functions of astrocytes in viral neuroinfections. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms.24043514. PubMed PMID: 36834929.","DOI":"10.3390\/ijms.24043514"},{"key":"860_CR56","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/brain\/awaf","volume":"148","author":"R Rust","year":"2025","unstructured":"Rust R, Yin H, Ach\u00f3n Buil B, Sagare AP, Kisler K. The blood-brain barrier: a help and a hindrance. Brain. 2025;148:2262\u201382. https:\/\/doi.org\/10.1093\/brain\/awaf. 068 PubMed PMID: 39969549.","journal-title":"Brain"},{"key":"860_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/exnr.1999.7237","volume":"161","author":"A Villa","year":"2000","unstructured":"Villa A, Snyder EY, Vescovi A, Mart\u00ednez-Serrano A. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol. 2000;161:67\u201384. https:\/\/doi.org\/10.1006\/exnr.1999.7237. PubMed PMID: 10683274.","journal-title":"Exp Neurol"},{"key":"860_CR58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/gt.2008.173","volume":"16","author":"I Rothenaigner","year":"2009","unstructured":"Rothenaigner I, Kramer S, Meggendorfer M, Rethwilm A, Brack-Werner R. Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression. Gene Ther. 2009;16:349\u201358. https:\/\/doi.org\/10.1038\/gt.2008.173. PubMed PMID: 19052634.","journal-title":"Gene Ther"},{"key":"860_CR59","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1097\/QAD.0b013e3282f12f27","volume":"21","author":"I Rothenaigner","year":"2007","unstructured":"Rothenaigner I, Kramer S, Ziegler M, Wolff H, Kleinschmidt A, Brack-Werner R. Long-term HIV-1 infection of neural progenitor populations. AIDS. 2007;21:2271\u201381. https:\/\/doi.org\/10.1097\/QAD.0b013e3282f12f27. PubMed PMID: 18090275.","journal-title":"AIDS"},{"key":"860_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/glia.23254","volume":"66","author":"C Kunze","year":"2018","unstructured":"Kunze C, B\u00f6rner K, Kienle E, Orschmann T, Rusha E, Schneider M, et al. Synthetic AAV\/CRISPR vectors for blocking HIV-1 expression in persistently infected astrocytes. Glia. 2018;66:413\u201327. https:\/\/doi.org\/10.1002\/glia.23254. PubMed PMID: 29119608.","journal-title":"Glia"},{"key":"860_CR61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12974-020-01756","volume":"17","author":"M Fares","year":"2020","unstructured":"Fares M, Cochet-Bernoin M, Gonzalez G, Montero-Menei CN, Blanchet O, Benchoua A, et al. Pathological modeling of TBEV infection reveals differential innate immune responses in human neurons and astrocytes that correlate with their susceptibility to infection. J Neuroinflammation. 2020;17:76. https:\/\/doi.org\/10.1186\/s12974-020-01756-. x PubMed PMID: 32127025.","journal-title":"J Neuroinflammation"},{"key":"860_CR62","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.csbj.2022.05.052","volume":"20","author":"M Selinger","year":"2022","unstructured":"Selinger M, V\u011bchtov\u00e1 P, Tykalov\u00e1 H, O\u0161lej\u0161kov\u00e1 P, Rumlov\u00e1 M, \u0160t\u011brba J, et al. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. Comput Struct Biotechnol J. 2022;20:2759\u201377. https:\/\/doi.org\/10.1016\/j.csbj.2022.05.052. PubMed PMID: 35685361.","journal-title":"Comput Struct Biotechnol J"},{"key":"860_CR63","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1099\/vir.0.068411-0","volume":"95","author":"M Palus","year":"2014","unstructured":"Palus M, B\u00edl\u00fd T, Elsterov\u00e1 J, Langhansov\u00e1 H, Sal\u00e1t J, Vancov\u00e1 M, et al. Infection and injury of human astrocytes by tick-borne encephalitis virus. J Gen Virol. 2014;95:2411\u201326. https:\/\/doi.org\/10.1099\/vir.0.068411-0. PubMed PMID: 25000960.","journal-title":"J Gen Virol"},{"key":"860_CR64","doi-asserted-by":"publisher","unstructured":"de Vries L, Harding AT. Mechanisms of neuroinvasion and neuropathogenesis by pathologic flaviviruses. Viruses. 2023;15. https:\/\/doi.org\/10.3390\/v15020261. PubMed PMID: 36851477.","DOI":"10.3390\/v15020261"},{"key":"860_CR65","doi-asserted-by":"publisher","first-page":"1182798","DOI":"10.3389\/fmicb.2023.1182798","volume":"14","author":"WD Tang","year":"2023","unstructured":"Tang WD, Tang HL, Peng HR, Ren RW, Zhao P, Zhao LJ. Inhibition of tick-borne encephalitis virus in cell cultures by ribavirin. Front Microbiol. 2023;14:1182798. https:\/\/doi.org\/10.3389\/fmicb.2023.1182798. PubMed PMID: 37378295.","journal-title":"Front Microbiol"},{"key":"860_CR66","unstructured":"National Center for Biotechnology Information. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Ribavirin.. PubChem Compound Summary for CID 37542, Ribavirin."},{"key":"860_CR67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.antiviral","volume":"81","author":"H Jeulin","year":"2009","unstructured":"Jeulin H, Venard V, Carapito D, Finance C, Kedzierewicz F. Effective ribavirin concentration in mice brain using cyclodextrin as a drug carrier: evaluation in a measles encephalitis model. Antiviral Res. 2009;81:261\u20136. https:\/\/doi.org\/10.1016\/j.antiviral..2008.12.006 PubMed PMID: 19133295.","journal-title":"Antiviral Res"},{"key":"860_CR68","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.stemcr.2017.02.021","volume":"8","author":"A Appelt-Menzel","year":"2017","unstructured":"Appelt-Menzel A, Cubukova A, G\u00fcnther K, Edenhofer F, Piontek J, Krause G, et al. Establishment of a human blood-brain barrier co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells. Stem Cell Rep. 2017;8:894\u2013906. https:\/\/doi.org\/10.1016\/j.stemcr.2017.02.021. PubMed PMID: 28344002.","journal-title":"Stem Cell Rep"},{"key":"860_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-026-00765-x","author":"J Admiraal","year":"2026","unstructured":"Admiraal J, Emeh PO, Bokkers M, de Ruiter SPM, Olivier T, Queiroz K, et al. Building the blood-brain barrier: a scalable self-assembling 3D model of the brain microvasculature under unidirectional flow. Fluids Barriers CNS. 2026. https:\/\/doi.org\/10.1186\/s12987-026-00765-x. PubMed PMID: 41578393.","journal-title":"Fluids Barriers CNS"},{"key":"860_CR70","doi-asserted-by":"publisher","unstructured":"Seo S, Nah S, Lee K, Choi N, Kim HN. Triculture model of in vitro BBB and its application to study BBB-associated chemosensitivity and drug delivery in glioblastoma. Adv Funct Mater. 2022;32. https:\/\/doi.org\/10.1002\/adfm.202106860.","DOI":"10.1002\/adfm.202106860"},{"key":"860_CR71","doi-asserted-by":"publisher","unstructured":"Du S, Hu X, Li P, Xu S, Kim M, Liu X, et al. Antiviral drug discovery and development: challenges and future directions. Signal Transduct Target Ther. 2026;11. https:\/\/doi.org\/10.1038\/s41392-025-02539-7. PubMed PMID: 41735249.","DOI":"10.1038\/s41392-025-02539-7"},{"key":"860_CR72","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrd2368","volume":"6","author":"R Cecchelli","year":"2007","unstructured":"Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, et al. Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov. 2007;6:650\u201361. https:\/\/doi.org\/10.1038\/nrd2368. PubMed PMID: 17667956.","journal-title":"Nat Rev Drug Discov"},{"key":"860_CR73","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.2147\/DDDT.S218708","volume":"13","author":"S Bagchi","year":"2019","unstructured":"Bagchi S, Chhibber T, Lahooti B, Verma A, Borse V, Jayant RD. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview. Drug Des Devel Ther. 2019;13:3591\u2013605. 10.2147. \/DDDT.S218708 PubMed PMID: 31695329.","journal-title":"Drug Des Devel Ther"},{"key":"860_CR74","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","volume":"9","author":"C Wallet","year":"2019","unstructured":"Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, et al. Microglial cells: The main HIV-1 reservoir in the brain. Front Cell Infect Microbiol. 2019;9:362. https:\/\/doi.org\/10.3389\/fcimb.2019.00362. PubMed PMID: 31709195.","journal-title":"Front Cell Infect Microbiol"},{"key":"860_CR75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.21697","volume":"66","author":"MJ Churchill","year":"2009","unstructured":"Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol. 2009;66:253\u20138. https:\/\/doi.org\/10.1002\/ana.21697. PubMed PMID: 19743454.","journal-title":"Ann Neurol"},{"key":"860_CR76","doi-asserted-by":"publisher","unstructured":"Schweitzer F, Letoha T, Osterhaus A, Prajeeth CK. Impact of tick-borne Orthoflaviviruses infection on compact human brain endothelial barrier. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26052342. PubMed PMID: 40076965.","DOI":"10.3390\/ijms26052342"},{"key":"860_CR77","doi-asserted-by":"publisher","unstructured":"Pran\u010dlov\u00e1 V, H\u00f6nig V, Zemanov\u00e1 M, R\u016f\u017eek D, Palus M. Robust CXCL10\/IP-10 and CCL5\/RANTES production induced by tick-borne encephalitis virus in human brain pericytes despite weak infection. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25147892. PubMed PMID: 39063134.","DOI":"10.3390\/ijms25147892"},{"key":"860_CR78","doi-asserted-by":"publisher","first-page":"e0126724","DOI":"10.1128\/jvi.01267-24","volume":"98","author":"J Quellec","year":"2024","unstructured":"Quellec J, Piro-Megy C, Cannac M, Nisole S, Marty FH, Gosselet F, et al. Rift Valley fever virus is able to cross the human blood-brain barrier in vitro by direct infection with no deleterious effects. J Virol. 2024;98:e0126724. . PubMed PMID: 39345143. https:\/\/doi.org\/10.1128\/jvi.01267-24","journal-title":"J Virol"},{"key":"860_CR79","doi-asserted-by":"publisher","unstructured":"Bohannon DG, Long D, Kim WK. Understanding the heterogeneity of human pericyte subsets in blood-brain barrier homeostasis and neurological diseases. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10040890. PubMed PMID: 33919664.","DOI":"10.3390\/cells10040890"},{"key":"860_CR80","doi-asserted-by":"publisher","first-page":"114443","DOI":"10.1016\/j.isci.2025.114443","volume":"29","author":"A Richards","year":"2026","unstructured":"Richards A, Khalil A, Bisht P, Whitfield TW, Gao X, Mooney D, et al. A human blood-brain barrier model reveals pericytes as critical regulators of viral neuroinvasion. iScience. 2026;29:114443. https:\/\/doi.org\/10.1016\/j.isci.2025.114443. PubMed PMID: 41541694.","journal-title":"iScience"},{"key":"860_CR81","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00018-022-04578-7","volume":"79","author":"P Tav\u010dar Verdev","year":"2022","unstructured":"Tav\u010dar Verdev P, Potokar M, Korva M, Resman Rus K, Kolenc M, Av\u0161i\u010d \u017dupanc T, et al. In human astrocytes neurotropic flaviviruses increase autophagy, yet their replication is autophagy-independent. Cell Mol Life Sci. 2022;79:566. https:\/\/doi.org\/10.1007\/s00018-022-04578-7. PubMed PMID: 36283999.","journal-title":"Cell Mol Life Sci"},{"key":"860_CR82","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-019-1596","volume":"16","author":"P Pokorna Formanova","year":"2019","unstructured":"Pokorna Formanova P, Palus M, Salat J, H\u00f6nig V, Stefanik M, Svoboda P, et al. Changes in cytokine and chemokine profiles in mouse serum and brain, and in human neural cells, upon tick-borne encephalitis virus infection. J Neuroinflammation. 2019;16:205. https:\/\/doi.org\/10.1186\/s12974-019-1596-. z PubMed PMID: 31699097.","journal-title":"J Neuroinflammation"},{"key":"860_CR83","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fmicb.2019.00525","volume":"10","author":"YM Mustaf\u00e1","year":"2019","unstructured":"Mustaf\u00e1 YM, Meuren LM, Coelho SVA, de Arruda LB. Pathways exploited by flaviviruses to counteract the blood-brain barrier and invade the central nervous system. Front Microbiol. 2019;10:525. https:\/\/doi.org\/10.3389\/fmicb.2019.00525. PubMed PMID: 30984122.","journal-title":"Front Microbiol"},{"key":"860_CR84","doi-asserted-by":"publisher","first-page":"e20472","DOI":"10.1371\/journal.pone.0020472","volume":"6","author":"D R\u016f\u017eek","year":"2011","unstructured":"R\u016f\u017eek D, Sal\u00e1t J, Singh SK, Kopeck\u00fd J. Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8\u2009+\u2009T-cells. PLoS ONE. 2011;6:e20472. https:\/\/doi.org\/10.1371\/journal.pone.0020472. PubMed PMID: 21629771.","journal-title":"PLoS ONE"},{"key":"860_CR85","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/cmi.12241","volume":"16","author":"AS Upadhyay","year":"2014","unstructured":"Upadhyay AS, Vonderstein K, Pichlmair A, Stehling O, Bennett KL, Dobler G, et al. Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity. Cell Microbiol. 2014;16:834\u201348. https:\/\/doi.org\/10.1111\/cmi.12241. PubMed PMID: 24245804.","journal-title":"Cell Microbiol"},{"key":"860_CR86","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.chom.2011.08.004","volume":"10","author":"RT Taylor","year":"2011","unstructured":"Taylor RT, Lubick KJ, Robertson SJ, Broughton JP, Bloom ME, Bresnahan WA, et al. TRIM79\u03b1, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe. 2011;10:185\u201396. PubMed PMID: 21925107.","journal-title":"Cell Host Microbe"},{"key":"860_CR87","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.3390\/cimb45080433","volume":"45","author":"PN Kamzeeva","year":"2023","unstructured":"Kamzeeva PN, Aralov AV, Alferova VA, Korshun VA. Recent advances in molecular mechanisms of nucleoside antivirals. Curr Issues Mol Biol. 2023;45:6851\u201379. https:\/\/doi.org\/10.3390\/cimb45080433. PubMed PMID: 37623252.","journal-title":"Curr Issues Mol Biol"},{"key":"860_CR88","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral","volume":"154","author":"KL Seley-Radtke","year":"2018","unstructured":"Seley-Radtke KL, Yates MK. The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold. Antiviral Res. 2018;154:66\u201386. https:\/\/doi.org\/10.1016\/j.antiviral. 2018.04.004 PubMed PMID: 29649496.","journal-title":"Antiviral Res"},{"key":"860_CR89","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.drudis.2022","volume":"27","author":"V Roy","year":"2022","unstructured":"Roy V, Agrofoglio LA. Nucleosides and emerging viruses: A new story. Drug Discov Today. 2022;27:1945\u201353. https:\/\/doi.org\/10.1016\/j.drudis.2022. 02.013 PubMed PMID: 35189369.","journal-title":"Drug Discov Today"},{"key":"860_CR90","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.dld.2010.10.007","volume":"43","author":"S Brillanti","year":"2011","unstructured":"Brillanti S, Mazzella G, Roda E. Ribavirin for chronic hepatitis C: and the mystery goes on. Dig Liver Dis. 2011;43:425\u201330. https:\/\/doi.org\/10.1016\/j.dld.2010.10.007. PubMed PMID: 21093391.","journal-title":"Dig Liver Dis"},{"key":"860_CR91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.virol.2023.06.002","volume":"585","author":"A Binderup","year":"2023","unstructured":"Binderup A, Galli A, Fossat N, Fernandez-Antunez C, Mikkelsen LS, Rivera-Rangel LR, et al. Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines. Virology. 2023;585:179\u201385. 06.002 PubMed PMID: 37356253.","journal-title":"Virology"},{"key":"860_CR92","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","volume":"1628","author":"H Qosa","year":"2015","unstructured":"Qosa H, Miller DS, Pasinelli P, Trotti D. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. Brain Res. 2015;1628:298\u2013316. https:\/\/doi.org\/10.1016\/j.brainres.2015.07.005. PubMed PMID: 26187753.","journal-title":"Brain Res"},{"key":"860_CR93","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2009.10.004","volume":"125","author":"H Potschka","year":"2010","unstructured":"Potschka H. Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach. Pharmacol Ther. 2010;125:118\u201327. https:\/\/doi.org\/10.1016\/j.pharmthera.2009.10.004. PubMed PMID: 19896502.","journal-title":"Pharmacol Ther"},{"key":"860_CR94","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022;12:3049\u201362. https:\/\/doi.org\/10.1016\/j.apsb.2022. 02.002 PubMed PMID: 35865092.","journal-title":"Acta Pharm Sin B"},{"key":"860_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","volume":"120","author":"VK Gribkoff","year":"2017","unstructured":"Gribkoff VK, Kaczmarek LK. The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes. Neuropharmacology. 2017;120:11\u20139. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.021. PubMed PMID: 26979921.","journal-title":"Neuropharmacology"},{"key":"860_CR96","doi-asserted-by":"publisher","unstructured":"Hubrecht RC, Carter E. The 3Rs and humane experimental technique: implementing change. Anim (Basel). 2019;9:754. \u00a0 PubMed PMID: 31575048 https:\/\/doi.org\/10.3390\/ani9100754","DOI":"10.3390\/ani9100754"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00860-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:20:25Z","timestamp":1790230825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00860-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00860-z","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"111"}}